|
Nose
/ Nasal congestion
|
| |
ephedrine hydrochloride
|
Not approved for prescribing
|
|
| |
Solution for injection |
|
Ephedrine hydrochloride (Non-proprietary)
|
|
| |
Oral tablet |
|
Ephedrine hydrochloride (Non-proprietary)
|
|
| |
pseudoephedrine hydrochloride
|
Not approved for prescribing
|
|
| |
Oral solution |
|
Galpseud (Thornton & Ross Ltd)
|
Not approved for prescribing
|
|
Sudafed Non-Drowsy Decongestant (McNeil Products Ltd)
|
Not approved for prescribing
|
| |
Oral tablet |
|
Galpseud (Thornton & Ross Ltd)
|
|
| |
xylometazoline hydrochloride
|
Joint formulary choice
|
|
| |
Spray |
|
Otrivine (Haleon UK Trading Ltd)
|
Joint formulary choice
|
|
Sudafed Non-Drowsy Decongestant (McNeil Products Ltd)
|
Not approved for prescribing
|
|
Sudafed Sinus-Ease (McNeil Products Ltd)
|
|
| |
Nasal drops |
|
Otrivine (Haleon UK Trading Ltd)
|
Joint formulary choice
|
|
Nose
/ Nasal infection
|
| |
betamethasone with neomycin
|
Not approved for prescribing
|
|
| |
Ear/eye/nose drops solution |
|
Betnesol-N (RPH Pharmaceuticals AB)
|
|
| |
Cutaneous ointment |
|
Betamethasone with neomycin (Non-proprietary)
|
|
| |
Cutaneous cream |
|
Betamethasone with neomycin (Non-proprietary)
|
|
| |
chlorhexidine with neomycin
|
Joint formulary choice
|
|
| |
Nasal cream |
|
Naseptin (Alliance Pharmaceuticals Ltd)
|
|
| |
mupirocin
|
Joint formulary choice
|
|
| |
Nasal ointment |
|
Bactroban (GlaxoSmithKline UK Ltd)
|
Joint formulary choice
|
| |
Cutaneous ointment |
|
Mupirocin (Non-proprietary)
|
|
|
Bactroban (GlaxoSmithKline UK Ltd)
|
|
| |
Cutaneous cream |
|
Bactroban (GlaxoSmithKline UK Ltd)
|
|
|
Nose
/ Nasal inflammation, nasal polyps and rhinitis
|
| |
azelastine hydrochloride
|
Joint formulary choice
|
|
|
Joint Prescribing Group's decision
October 2019 - the JPG agreed to approved the addition of Rhinolast® (azelastine nasal spray) to the joint formulary for allergic rhinitis.
|
|
| |
Eye drops |
|
Azelastine hydrochloride (Non-proprietary)
|
|
|
Optilast (Viatris UK Healthcare Ltd)
|
|
| |
Spray |
|
Azelair (Viatris UK Healthcare Ltd)
|
|
|
Rhinolast (Viatris UK Healthcare Ltd)
|
Joint formulary choice
|
| |
beclometasone dipropionate
|
Joint formulary choice
|
|
| |
Modified-release tablet |
|
Clipper (Chiesi Ltd)
|
|
| |
Pressurised inhalation |
|
Beclu (Lupin Healthcare (UK) Ltd)
|
|
|
Clenil Modulite (Chiesi Ltd)
|
|
|
Kelhale (Cipla EU Ltd)
|
|
|
Qvar (Teva UK Ltd)
|
|
|
Qvar Autohaler (Teva UK Ltd)
|
|
|
Qvar Easi-Breathe (Teva UK Ltd)
|
|
|
Soprobec (Glenmark Pharmaceuticals Europe Ltd)
|
|
| |
Inhalation powder |
|
Easyhaler (Orion Pharma (UK) Ltd)
|
|
| |
Spray |
|
Beclometasone dipropionate (Non-proprietary)
|
Joint formulary choice
|
|
Beconase (GlaxoSmithKline UK Ltd, Omega Pharma Ltd)
|
Joint formulary choice
|
|
Nasobec (Teva UK Ltd)
|
Joint formulary choice
|
| |
Cutaneous ointment |
|
Beclometasone dipropionate (Non-proprietary)
|
|
| |
Cutaneous cream |
|
Beclometasone dipropionate (Non-proprietary)
|
|
| |
betamethasone
|
Joint formulary choice
|
|
| |
Soluble tablet |
|
Betamethasone (Non-proprietary)
|
|
| |
Solution for injection |
|
Betamethasone (Non-proprietary)
|
|
| |
Ear/eye/nose drops solution |
|
Betnesol (RPH Pharmaceuticals AB)
|
|
|
Vistamethasone (Martindale Pharmaceuticals Ltd)
|
|
| |
Medicated plaster |
|
Betesil (Derma UK Ltd)
|
|
| |
Cutaneous ointment |
|
Betamethasone (Non-proprietary)
|
|
|
Audavate (Accord-UK Ltd)
|
|
|
Betnovate (GlaxoSmithKline UK Ltd)
|
|
|
Diprosone (Organon Pharma (UK) Ltd)
|
|
| |
Cutaneous foam |
|
Bettamousse (RPH Pharmaceuticals AB)
|
|
| |
Cutaneous cream |
|
Betamethasone (Non-proprietary)
|
|
|
Audavate (Accord-UK Ltd)
|
|
|
Betnovate (GlaxoSmithKline UK Ltd)
|
|
|
Diprosone (Organon Pharma (UK) Ltd)
|
|
| |
Cutaneous liquid |
|
Betacap (Dermal Laboratories Ltd)
|
|
|
Betnovate (GlaxoSmithKline UK Ltd)
|
|
|
Diprosone (Organon Pharma (UK) Ltd)
|
|
| |
budesonide
|
Not approved for prescribing
|
NICE TA708
NICE TA937
|
| |
Orodispersible tablet |
|
Jorveza (Dr. Falk Pharma UK Ltd)
|
|
| |
Modified-release tablet |
|
Cortiment (Ferring Pharmaceuticals Ltd)
|
|
| |
Modified-release capsule |
|
Budesonide (Non-proprietary)
|
|
|
Kinpeygo (Genus Pharmaceuticals Holdings Ltd)
|
|
| |
Gastro-resistant capsule |
|
Budenofalk (Dr. Falk Pharma UK Ltd)
|
|
| |
Gastro-resistant granules |
|
Budenofalk (Dr. Falk Pharma UK Ltd)
|
|
| |
Inhalation powder |
|
Budelin Novolizer (Viatris UK Healthcare Ltd)
|
|
|
Easyhaler (Orion Pharma (UK) Ltd)
|
|
|
Pulmicort Turbohaler (AstraZeneca UK Ltd)
|
|
| |
Nebuliser liquid |
|
Budesonide (Non-proprietary)
|
|
|
Pulmicort Respules (AstraZeneca UK Ltd)
|
|
| |
Enema |
|
Entocort (Tillotts Pharma UK Ltd)
|
|
| |
Spray |
|
Budesonide (Non-proprietary)
|
Not approved for prescribing
|
| |
Rectal foam |
|
Budenofalk (Dr. Falk Pharma UK Ltd)
|
|
| |
desloratadine
|
Not approved for prescribing
|
|
| |
Oral solution |
|
Desloratadine (Non-proprietary)
|
Not approved for prescribing
|
|
Neoclarityn (Organon Pharma (UK) Ltd)
|
Not approved for prescribing
|
| |
Oral tablet |
|
Desloratadine (Non-proprietary)
|
|
|
Neoclarityn (Organon Pharma (UK) Ltd)
|
|
| |
dupilumab
|
Non-formulary at HHFT and not suitable for primary care prescribing
|
NICE TA534
NICE TA751
NICE TA955
|
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.
|
|
| |
Solution for injection |
|
Dupixent (Sanofi)
|
Non-formulary at HHFT and not suitable for primary care prescribing
|
| |
fexofenadine hydrochloride
|
Joint formulary choice
|
|
| |
Oral tablet |
|
Fexofenadine hydrochloride (Non-proprietary)
|
|
|
Telfast (Sanofi Consumer Healthcare)
|
|
| |
fluticasone
|
Joint formulary choice
|
|
| |
Pressurised inhalation |
|
Flixotide Evohaler (GlaxoSmithKline UK Ltd)
|
|
| |
Inhalation powder |
|
Flixotide Accuhaler (GlaxoSmithKline UK Ltd)
|
|
| |
Spray |
|
Fluticasone (Non-proprietary)
|
Joint formulary choice
|
|
Avamys (GlaxoSmithKline UK Ltd)
|
Specialist knowledge/initiation
|
|
Coryen (Alissa Healthcare Research Ltd)
|
|
|
Flixonase (GlaxoSmithKline UK Ltd, Haleon UK Trading Ltd)
|
Joint formulary choice
|
|
Nasofan (Teva UK Ltd)
|
Joint formulary choice
|
| |
Nasal drops |
|
Fluticasone (Non-proprietary)
|
|
| |
Cutaneous ointment |
|
Cutivate (GlaxoSmithKline UK Ltd)
|
|
| |
Cutaneous cream |
|
Fluticasone (Non-proprietary)
|
|
| |
fluticasone with azelastine
|
Joint formulary choice
|
|
|
Joint Prescribing Group's decision
October 2019 - the JPG agreed to approved the addition of Dymista® (fluticasone with azelastine nasal spray) to the joint formulary for allergic rhinitis.
|
|
| |
Spray |
|
Dymista (Viatris UK Healthcare Ltd)
|
Joint formulary choice
|
| |
ipratropium bromide
|
Not approved for prescribing
|
|
| |
Pressurised inhalation |
|
Atrovent (Boehringer Ingelheim Ltd)
|
|
|
Inhalvent (Alissa Healthcare Research Ltd)
|
|
| |
Nebuliser liquid |
|
Ipratropium bromide (Non-proprietary)
|
|
|
Atrovent UDV (Boehringer Ingelheim Ltd)
|
|
| |
Spray |
|
Ipratropium bromide (Non-proprietary)
|
|
| |
ketotifen
|
Not approved for prescribing
|
|
| |
Oral solution |
|
Zaditen (CD Pharma Srl)
|
Not approved for prescribing
|
| |
Eye drops |
|
Ketofall (Scope Ophthalmics Ltd)
|
|
|
Zaditen (Thea Pharmaceuticals Ltd)
|
Not approved for prescribing
|
| |
Oral tablet |
|
Zaditen (CD Pharma Srl)
|
|
| |
mometasone furoate
|
Joint formulary choice
|
|
| |
Inhalation powder |
|
Asmanex Twisthaler (Organon Pharma (UK) Ltd)
|
|
| |
Spray |
|
Mometasone furoate (Non-proprietary)
|
Joint formulary choice
|
|
Nasonex (Organon Pharma (UK) Ltd)
|
Joint formulary choice
|
| |
Cutaneous ointment |
|
Mometasone furoate (Non-proprietary)
|
|
|
Elocon (Organon Pharma (UK) Ltd)
|
|
| |
Cutaneous cream |
|
Mometasone furoate (Non-proprietary)
|
|
|
Elocon (Organon Pharma (UK) Ltd)
|
|
| |
Cutaneous liquid |
|
Elocon (Organon Pharma (UK) Ltd)
|
|
| |
mometasone furoate with olopatadine
|
|
|
| |
Spray |
|
Ryaltris (Glenmark Pharmaceuticals Europe Ltd)
|
|
| |
rupatadine
|
Not approved for prescribing
|
|
| |
Oral tablet |
|
Rupatadine (Non-proprietary)
|
|
| |
triamcinolone acetonide
|
Not approved for prescribing
|
|
| |
Suspension for injection |
|
Triamcinolone acetonide (Non-proprietary)
|
|
|
Adcortyl Intra-articular / Intradermal (Bristol-Myers Squibb Pharmaceuticals Ltd)
|
|
|
Kenalog (Bristol-Myers Squibb Pharmaceuticals Ltd)
|
Not approved for prescribing
|
| |
Spray |
|
Nasacort (Sanofi Consumer Healthcare)
|
Not approved for prescribing
|